Federal Register / Vol. 69, No. 233 / Monday, December 6, 2004 / Notices 70471

Drug Schedule 

Codeine (9050) ............................. II 

Oxycodone (9143) ........................ II 

Hydromorphone (9150) ................. II 

Hydrocodone (9193) ..................... II 

Morphine (9300) ........................... II 

Thebaine (9333) ........................... II 

Alfentanil (9737) ............................ II 

Sufentanil (9740) .......................... II 

Fentanyl (9801) ............................. II 

The company plans to manufacture 

the listed controlled substances in bulk 

for distribution to its customers. 

Any other such applicant and any 

person who is presently registered with 

DEA to manufacture such substances 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such comments or objections 

may be addressed, in quintuplicate, to 

the Deputy Assistant Administrator, 

Office of Diversion Control, Drug 

Enforcement Administration, United 

States Department of Justice, 

Washington, DC 20537, Attention: DEA 

Federal Register Representative, Office 

of Liaison and Policy (ODLR) and must 

be filed no later than February 4, 2005.

Dated: November 22, 2004. 

William J. Walker, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration.

[FR Doc. 04–26736 Filed 12–3–04; 8:45 am] 

BILLING CODE 4410–01–P

DEPARTMENT OF JUSTICE

Drug Enforcement Administration 

Manufacturer of Controlled 

Substances; Notice of Application 

Pursuant to section 1301.33(a) of Title 

21 of the Code of Federal Regulations 

(CFR), this is notice that on August 19, 

2004, Organichem, Corporation, 33 

Riverside Avenue, Rensselaer, New 

York 12144, made application by 

renewal to the Drug Enforcement 

Administration (DEA) for registration as 

a bulk manufacturer of the basic classes 

of controlled substances listed:

Drug Schedule 

Tetrahydrocannabinols (7370) ...... I 

Amphetamine (1100) .................... II 

Methylphenidate (1724) ................ II 

Pentobarbital (2270) ..................... II 

Meperidine (9230) ......................... II 

Dextropoxyphene (9273) .............. II 

The company plans to manufacture 

bulk controlled substances for use 

internally and for distribution to its 

customers. 

Any other such applicant and any 

person who is presently registered with 

DEA to manufacture such substances 

may file comments or objections to the 

issuance of the proposed registration 

pursuant to 21 CFR 1301.33(a). 

Any such comments or objections 

may be addressed, in quintuplicate, to 

the Deputy Assistant Administrator, 

Office of Diversion Control, Drug 

Enforcement Administration, United 

States Department of Justice, 

Washington, DC 20537, Attention: DEA 

Federal Register Representative, Office 

of Liaison and Policy (ODLR) and must 

be filed no later than February 4, 2005.

Dated: November 22, 2004. 

William J. Walker, 

Deputy Assistant Administrator, Office of 

Diversion Control, Drug Enforcement 

Administration.

[FR Doc. 04–26737 Filed 12–3–04; 8:45 am] 

BILLING CODE 4410–09–P

NATIONAL SCIENCE FOUNDATION

Notice of Permit Applications Received 

Under the Antarctic Conservation Act 

of 1978 (Pub. L. 95–541)

AGENCY: National Science Foundation.

ACTION: Notice of Permit Applications 

Received under the Antarctic 

Conservation Act of 1978, Pub. L. 95–

541. 

SUMMARY: The National Science 

Foundation (NSF) is required to publish 

notice of permit applications received to 

conduct activities regulated under the 

Antarctic Conservation Act of 1978. 

NSF has published regulations under 

the Antarctic Conservation Act at Title 

45 part 670 of the Code of Federal 

Regulations. This is the required notice 

of permit applications received.

DATES: Interested parties are invited to 

submit written data, comments, or 

views with respect to this permit 

application by January 5, 2005. This 

application may be inspected by 

interested parties at the Permit Office, 

address below.

ADDRESSES: Comments should be 

addressed to Permit Office, Room 755, 

Office of Polar Programs, National 

Science Foundation, 4201 Wilson 

Boulevard, Arlington, Virginia 22230.

FOR FURTHER INFORMATION CONTACT:

Nadene G. Kennedy at the above 

address or (703) 292–7405.

SUPPLEMENTARY INFORMATION: The 

National Science Foundation, as 

directed by the Antarctic Conservation 

Act of 1978 (Pub. L. 95–541), as 

amended by the Antarctic Science, 

Tourism and Conservation Act of 1996, 

has developed regulations for the 

establishment of a permit system for 

various activities in Antarctica and 

designation of certain animals and 

certain geographic areas a requiring 

special protection. The regulations 

establish such a permit system to 

designate Antarctic Specially Protected 

Areas. 

The applications received are as 

follows: 

1. Applicant: Permit Application No. 

2005–017, Peter Doran Earth and 

Environmental Sciences (MC186), 

University of Illinois at Chicago, 

Chicago, IL 60607. 

Activity for Which Permit Is Requested 

Take. The applicant plans to collect 

bone samples from mummified 

penguins and seals located on the ice 

surface of the Dry Valley lakes. The 

radiocarbon dates of the bones may help 

to determine the age of the lake ice 

covers. 

Location 

Taylor Valley Lakes. 

Dates 

December 1, 2004 to February 15, 

2005.

Nadene G. Kennedy, 

Permit Officer, Office of Polar Programs.

[FR Doc. 04–26675 Filed 12–3–04; 8:45 am] 

BILLING CODE 7555–01–M

NUCLEAR REGULATORY 

COMMISSION 

[Docket Nos. 50–325 and 50–324] 

Carolina Power & Light Company, 

Brunswick Steam Electric Plant, Units 

1 and 2; Notice of Acceptance for 

Docketing of the Application and 

Notice of Opportunity for Hearing 

Regarding Renewal of Facility 

Operating License Nos. DPR–71 and 

DPR–62 for an Additional 20-Year 

Period 

The U.S. Nuclear Regulatory 

Commission (NRC or Commission) is 

considering an application for the 

renewal of Operating License Nos. DPR–

71 and DPR–62, which authorizes the 

Carolina Power & Light Company, now 

doing business as Progress Energy 

Carolinas, Inc. (PEC), to operate 

Brunswick Steam Electric Plant, at 2,923 

megawatts thermal for Unit 1, and 2,923 

megawatts thermal for Unit 2. The 

renewed licenses would authorize the 

applicant to operate the Brunswick 

Steam Electric Plant, Units 1 and 2, for 

an additional 20 years beyond the 

period specified in the current licenses.